{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:19:24Z","timestamp":1789906764579,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003480","name":"Jiangsu Medical College","doi-asserted-by":"publisher","award":["20229109"],"award-info":[{"award-number":["20229109"]}],"id":[{"id":"10.13039\/501100003480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.prostaglandins.2025.106987","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T01:12:56Z","timestamp":1743642776000},"page":"106987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["GLP-1RAs regulate lipid metabolism and induce autophagy through AMPK\/SIRT1 pathway to improve NAFLD"],"prefix":"10.1016","volume":"178","author":[{"given":"Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-8040","authenticated-orcid":false,"given":"Chunyan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","article-title":"Healthcare and socioeconomic costs of NAFLD: a global framework to navigate the uncertainties","volume":"79","author":"Allen","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib2","article-title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","volume":"46","author":"Baggio","year":"2020","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-020-14384-z","article-title":"Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase","volume":"11","author":"Byun","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106067","article-title":"Sulfated glucuronomannan hexasaccharide G6S1 enhanced lipolysis and lipophagy via PPAR alpha pathway","volume":"139","author":"Cai","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2015.11.012","article-title":"Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice","volume":"770","author":"Chen","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2025.106987_bib6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41401-021-00836-9","article-title":"GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis","volume":"43","author":"Chen","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.prostaglandins.2025.106987_bib7","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114824","article-title":"Emerging roles of ATG7 in human health and disease","volume":"13","author":"Collier","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpsychires.2023.05.041","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review","volume":"164","author":"Cooper","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.prostaglandins.2025.106987_bib9","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s42255-021-00489-2","article-title":"Peroxisomal beta-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis","volume":"3","author":"Ding","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.602574","article-title":"Liraglutide alleviates hepatic steatosis by activating the TFEB-regulated autophagy-lysosomal pathway","volume":"8","author":"Fang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/15548627.2023.2247300","article-title":"Interplay of energy metabolism and autophagy","volume":"20","author":"Feng","year":"2024","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","article-title":"The menage a trois of autophagy, lipid droplets and liver disease","volume":"18","author":"Filali-Mouncef","year":"2022","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.prostaglandins.2025.106987_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13679-021-00431-3","article-title":"Endoplasmic reticulum stress and autophagy in the pathogenesis of non-alcoholic fatty liver disease (NAFLD): current evidence and perspectives","volume":"10","author":"Flessa","year":"2021","journal-title":"Curr. Obes. Rep."},{"issue":"10403","key":"10.1016\/j.prostaglandins.2025.106987_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(23)01163-7","article-title":"Efficacy and safety of co-administered once-weekly cagrilintide 2\u00b74 mg with once-weekly semaglutide 2\u00b74 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial","volume":"402","author":"Frias","year":"2023","journal-title":"Lancet"},{"issue":"43","key":"10.1016\/j.prostaglandins.2025.106987_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031437","article-title":"Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology","volume":"101","author":"Huang","year":"2022","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.prostaglandins.2025.106987_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cld.2023.01.016","article-title":"Research priorities for precision medicine in NAFLD","volume":"27","author":"Iruzubieta","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1096064","article-title":"Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: a network meta-analysis","volume":"13","author":"Jin","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155772","article-title":"GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-\u03b21\/SMAD3 pathway","volume":"152","author":"Jurado-Aguilar","year":"2024","journal-title":"Metab. Clin. Exp."},{"issue":"5","key":"10.1016\/j.prostaglandins.2025.106987_bib19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.prostaglandins.2025.106987_bib20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2021.04.074","article-title":"Preparing for the NASH epidemic: a call to action","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2025.106987_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/life12020318","article-title":"SIRT1: a key player in male reproduction","volume":"12","author":"Khawar","year":"2022","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.prostaglandins.2025.106987_bib22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/hep.32235","article-title":"A GLP-1\/GLP-2 receptor dual agonist to treat NASH: targeting the gut-liver axis and microbiome","volume":"75","author":"Kim","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib23","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v13.i1.6","article-title":"Autophagy in liver diseases","volume":"13","author":"Kouroumalis","year":"2021","journal-title":"World J. Hepatol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2025.106987_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114933","article-title":"Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease","volume":"197","author":"Li","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.prostaglandins.2025.106987_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biom13081199","article-title":"Combination of Pioglitazone and metformin actions on liver lipid metabolism in obese mice","volume":"13","author":"Liu","year":"2023","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.prostaglandins.2025.106987_bib27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41574-022-00711-5","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122343","article-title":"Research progress on rodent models and its mechanisms of liver injury","volume":"337","author":"Mao","year":"2024","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.prostaglandins.2025.106987_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib30","article-title":"Redefining the role of AMPK in autophagy and the energy stress response","volume":"14","author":"Park","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.prostaglandins.2025.106987_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib32","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/clinem\/dgad395","article-title":"Posttransplant diabetes mellitus: recent developments in pharmacological management of hyperglycemia","volume":"109","author":"Pena","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.prostaglandins.2025.106987_bib33","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.cgh.2023.03.042","article-title":"Noninvasive assessment of liver fibrosis in NAFLD","volume":"21","author":"Sanyal","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"7242","key":"10.1016\/j.prostaglandins.2025.106987_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prostaglandins.2025.106987_bib35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/13543784.2021.1951701","article-title":"Anti-diabetic drugs and NASH: from current options to promising perspectives","volume":"30","author":"Smati","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/15548627.2014.984271","article-title":"Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway","volume":"11","author":"Song","year":"2015","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.prostaglandins.2025.106987_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S2468-1253(22)00338-7","article-title":"Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease","volume":"8","author":"Targher","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.prostaglandins.2025.106987_bib38","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.prostaglandins.2025.106987_bib39","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"issue":"5","key":"10.1016\/j.prostaglandins.2025.106987_bib40","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s12072-023-10568-z","article-title":"Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes","volume":"17","author":"Vaz","year":"2023","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1015500","article-title":"Role of AMPK in autophagy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-023-01085-y","article-title":"Effects of SGLT-2 inhibitors on adipose tissue distribution in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Wang","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"issue":"3","key":"10.1016\/j.prostaglandins.2025.106987_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.prostaglandins.2025.106987_bib44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fphar.2020.00432","article-title":"Liraglutide attenuates non-alcoholic fatty liver disease in mice by regulating the local renin-angiotensin system","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2025.106987_bib45","article-title":"Macrophage STING-YAP axis controls hepatic steatosis by promoting autophagic degradation of lipid droplets","author":"Yang","year":"2023","journal-title":"Hepatology"},{"issue":"6478","key":"10.1016\/j.prostaglandins.2025.106987_bib46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1126\/science.aay0542","article-title":"An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis","volume":"367","author":"Zhao","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.prostaglandins.2025.106987_bib47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882325000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882325000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:54:31Z","timestamp":1762365271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882325000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S1098882325000401"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2025.106987","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1RAs regulate lipid metabolism and induce autophagy through AMPK\/SIRT1 pathway to improve NAFLD","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2025.106987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106987"}}